SCHEMBL14919980

SCHEMBL14919980

NCc1ccc(F)c(OC2=COC(Cc3ccccc3)O2)c1F

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.30
MAOA P21397 1/20 0.30
MAOB P27338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL921631 0.76 MAOB (0.42) MAOB
SCHEMBL922992 0.74 LOXL2 (0.37) MAOB
Hydrochloric Acid SCHEMBL14920986 0.70 CA12 (0.41) MAOB
SCHEMBL921952 0.67
SCHEMBL3524878 0.67 SLC6A2 (0.32)
SCHEMBL920810 0.64
SCHEMBL921079 0.64 MGLL (0.43) KDM1AMAOAMAOB
SCHEMBL632476 0.64 HTR2A (0.44) MAOAMAOB
SCHEMBL74038 0.64
SCHEMBL5754991 0.63 TAAR1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773613-A1 SUBSTITUTED BENZYLAMINE COMPOUNDS, THEIR USE IN MEDICINE, AND IN PARTICULAR THE TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTION Astex Therapeutics Limited (GB) 2014-09-10 EP disclosed
WO-2013064538-A1 SUBSTITUTED BENZYLAMINE COMPOUNDS, THEIR USE IN MEDICINE, AND IN PARTICULAR THE TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTION ASTEX THERAPEUTICS LIMITED (GB) 2013-05-10 WO disclosed